Overexpression of miR-130a could lead to drug resistance while downregulation of miR-130a could overcome cisplatin resistance by targeting MDR1/P-glycoprotein in SKOV3/CIS cells [16]. The gene discussed is ABCB1; the disease is in situ carcinoma.